Condensed Consolidated Balance Sheets (Unaudited) (USD $) In Thousands, unless otherwise specified	Sep. 30, 2013	Dec. 31, 2012
Current Assets:
Cash and cash equivalents	$ 31,346	$ 361
Restricted cash and restricted cash equivalents	800
Accounts receivable	12,376	3,089
Inventories	11,746	7,095
Prepaid expenses and other assets	1,457	1,344
Total current assets	57,725	11,889
Property and equipment, net	8,267	6,791
Other assets	44	61
Total assets	66,036	18,741
Current Liabilities:
Accounts payable and accrued expenses	12,221	5,971
Accrued compensation	3,030	1,392
Other current liabilities	144	508
Deferred patient discount program	1,557	1,540
Deferred revenue	1,510	3,767
Line of credit		11,858
Notes payable to related party, including interest		58,383
Total current liabilities	18,462	83,419
Total liabilities	18,462	83,419
Commitments and contingencies (see Note 7)
Stockholders’ Equity (Deficit):
Convertible preferred stock (par value $0.01 per share, 10,000,000 and 15,000,000 shares authorized as of September 30, 2013 and December 31, 2012, respectively; 0 and 14,864,607 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively)		149
Common stock (par value $0.0002145 per share, 50,000,000 and 25,000,000 shares authorized as of September 30, 2013 and December 31, 2012, respectively; 21,414,343 and 856,026 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively)	5
Additional paid in capital	160,723	64,604
Notes receivable from stockholders	(21)	(21)
Accumulated deficit	(113,133)	(129,410)
Total stockholders’ equity (deficit)	47,574	(64,678)
Total liabilities and stockholders’ equity (deficit)	$ 66,036	$ 18,741